JPWO2023076902A5 - - Google Patents
Info
- Publication number
- JPWO2023076902A5 JPWO2023076902A5 JP2024524728A JP2024524728A JPWO2023076902A5 JP WO2023076902 A5 JPWO2023076902 A5 JP WO2023076902A5 JP 2024524728 A JP2024524728 A JP 2024524728A JP 2024524728 A JP2024524728 A JP 2024524728A JP WO2023076902 A5 JPWO2023076902 A5 JP WO2023076902A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- lipid nanoparticles
- mol
- poegma
- dlin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271595P | 2021-10-25 | 2021-10-25 | |
| US63/271,595 | 2021-10-25 | ||
| PCT/US2022/078659 WO2023076902A1 (en) | 2021-10-25 | 2022-10-25 | Poegma-based lipid nanoparticles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024541924A JP2024541924A (ja) | 2024-11-13 |
| JP2024541924A5 JP2024541924A5 (https=) | 2025-10-31 |
| JPWO2023076902A5 true JPWO2023076902A5 (https=) | 2025-10-31 |
Family
ID=86158533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524728A Pending JP2024541924A (ja) | 2021-10-25 | 2022-10-25 | Ｐｏｅｇｍａベース脂質ナノ粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250049729A1 (https=) |
| EP (1) | EP4422605A4 (https=) |
| JP (1) | JP2024541924A (https=) |
| CN (1) | CN118201605A (https=) |
| CA (1) | CA3236153A1 (https=) |
| WO (1) | WO2023076902A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117562869B (zh) * | 2023-05-05 | 2024-07-16 | 中南大学湘雅医院 | 一种治疗关节疼痛的氢氧化镁纳米粒、其制备方法及应用 |
| WO2025067389A1 (en) * | 2023-09-28 | 2025-04-03 | Immorna (hangzhou) Biotechnology Co., Ltd. | Lipid complex nanoparticle for lung-targeted delivery of nucleic acid therapeutic agent |
| WO2025081189A1 (en) * | 2023-10-12 | 2025-04-17 | Georgia Tech Research Corporation | Methods and compositions for lipid nanoparticle (lnp) mediated delivery of mrna encoded synthetic antigens for universal tumor targeting by car t cells |
| CN118001253A (zh) * | 2024-02-07 | 2024-05-10 | 北京大学 | 一种肾脏靶向mRNA-LNP递送技术和疾病治疗方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799565B2 (en) * | 2004-06-07 | 2010-09-21 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering RNA |
| US8497356B2 (en) | 2009-02-17 | 2013-07-30 | Duke University | Biomolecule polymer conjugates and methods for making the same |
| US10364451B2 (en) | 2013-05-30 | 2019-07-30 | Duke University | Polymer conjugates having reduced antigenicity and methods of using the same |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| WO2017112825A2 (en) | 2015-12-21 | 2017-06-29 | Duke University | Polymer conjugates having reduced antigenicity and methods of using the same |
| WO2020051220A1 (en) | 2018-09-04 | 2020-03-12 | The Board of the Regents of the University of Texas System | Compositions and methods for organ specific delivery of nucleic acids |
| CN112996519B (zh) * | 2018-09-04 | 2025-02-28 | 德克萨斯大学系统董事会 | 用于核酸的器官特异性递送的组合物和方法 |
| AU2021232069A1 (en) * | 2020-03-05 | 2022-11-03 | Flagship Pioneering Innovations Vi, Llc | Host defense suppressing methods and compositions for modulating a genome |
| MX2023000806A (es) * | 2020-07-17 | 2023-04-11 | Generation Bio Co | Métodos para encapsular polinucleótidos en tamaños reducidos de nanopartículas lipídicas y formulación novedosa de estos. |
| CN112961065B (zh) * | 2021-02-05 | 2023-03-14 | 嘉晨西海(杭州)生物技术有限公司 | 一种可电离脂质分子及其制备方法及其在制备脂质纳米颗粒的应用 |
| WO2022212911A1 (en) | 2021-04-01 | 2022-10-06 | Duke University | Poegma copolymer conjugates and methods of treating diseases |
-
2022
- 2022-10-25 CN CN202280071413.1A patent/CN118201605A/zh active Pending
- 2022-10-25 JP JP2024524728A patent/JP2024541924A/ja active Pending
- 2022-10-25 CA CA3236153A patent/CA3236153A1/en active Pending
- 2022-10-25 US US18/704,387 patent/US20250049729A1/en active Pending
- 2022-10-25 WO PCT/US2022/078659 patent/WO2023076902A1/en not_active Ceased
- 2022-10-25 EP EP22888435.9A patent/EP4422605A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6852334B1 (en) | Cationic peg-lipids and methods of use | |
| JP2022184875A5 (https=) | ||
| AU783647B2 (en) | Cationic peg-lipids and methods of use | |
| US9415109B2 (en) | Stable non-aggregating nucleic acid lipid particle formulations | |
| US11938227B2 (en) | Lipid nanoparticles encapsulation of large RNA | |
| AU2022434120A1 (en) | Cationic lipid compound, composition containing same and use thereof | |
| US10626393B2 (en) | Delivering CRISPR therapeutics with lipid nanoparticles | |
| EP2743265B1 (en) | Improved amino lipids and methods for the delivery of nucleic acids | |
| EP1328254B1 (en) | Lipid formulations for target delivery | |
| US20220160899A1 (en) | Compositions and methods for delivering messenger rna | |
| US6986902B1 (en) | Polyanionic polymers which enhance fusogenicity | |
| JP2019218349A5 (https=) | ||
| WO2006007712A1 (en) | Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents | |
| JP2011507534A5 (https=) | ||
| US20080145413A1 (en) | Lipids and lipid assemblies comprising transfection enhancer elements | |
| JPWO2023076902A5 (https=) | ||
| EP1100834B1 (en) | Polyanionic polymers which enhance fusogenicity | |
| EP1938843A1 (en) | Lipids and lipid assemblies comrising transfection enhancer elements | |
| JPWO2023019310A5 (https=) |